Added to YB: 2025-12-13
Pitch date: 2025-12-12
NXGL [bullish]
NEXGEL, Inc.
Author Info
Ahead of the Curve focuses on identifying and owning great small cap companies. Sign up for the newsletter.
Company Info
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
Market Cap
$12.2M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-6.74
P/E
-3.97
EV/Sales
1.27
Sector
Health Care Equipment and Supplies
Category
special_situation
NXGL: Today's spinoff worth half the current market cap?
NXGL: NexGel spun drug delivery assets into NexGelRx, raising $8M external capital while retaining 19.99% equity + 5% royalty + exclusive manufacturing rights. E-beam hydrogel tech shows superior drug delivery vs chemical patches. Risk-adjusted DCF suggests $0.93/share value from spinoff alone vs $1.93 current price.
Read full article (5 min)